CTRI/2009/091/000607已完成3 期
A phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant - L00070 IN 305 B0
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 764
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients must give written informed consent
- •2. Women with confirmed carcinoma of the breast.
- •3. Patients must have received a minimum cumulative dose of anthracycline or be resistant to an anthracycline
- •4. Patients must be resistant to taxane therapy
排除标准
- •1.Patients having received > 3 regimens of chemotherapy
- •2.Prior therapy with capecitabine and/or vinca alkaloids (including vinflunine).
研究者
相似试验
进行中（未招募）
不适用
A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistantBreast cancer metastaticMedDRA version: 11.0Level: LLTClassification code 10055113Term: <Manually entered code. Term in E.1.1>EUCTR2008-004171-21-CZPIERRE FABRE MEDICAMENT764
进行中（未招募）
不适用
A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant - NDWoman with metastatic breast cancerMedDRA version: 9.1Level: LLTClassification code 10055113Term: Breast cancer metastaticEUCTR2008-004171-21-ITPierre Fabre Medicament764
进行中（未招募）
1 期
A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistantBreast cancer metastaticMedDRA version: 11.0Level: LLTClassification code 10055113Term: <Manually entered code. Term in E.1.1>EUCTR2008-004171-21-EEPIERRE FABRE MEDICAMENT770
进行中（未招募）
不适用
Trial of Vinflunine Plus Capecitabine versus Capecitabine alone in Advanced Breast Cancer Patients who - were previously treated with an anthracycline or are resistant to an anthracycline and - who are taxane resistantBreast cancer metastaticMedDRA version: 16.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-004171-21-HUPIERRE FABRE MEDICAMENT764
进行中（未招募）
1 期
A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistantEUCTR2008-004171-21-FRPIERRE FABRE MEDICAMENT770